Significant strengths in protein therapeutics, genomics and systems pharmacology allow us to maintain top 25 ranking by the American Association of Colleges of Pharmacy for research funding.
Industry-leading employers recognize our commitment to academic excellence—our graduates boast diverse leadership roles in all practice areas of pharmacy and pharmaceutical sciences.
We are ranked #1 in New York State and #22 in the United States by U.S. News & World Report, and the premier flagship school of pharmacy in the State University of New York system.
Boldly Buffalo is a fundraising campaign that will transform UB—and the School of Pharmacy and Pharmaceutical Sciences—in nearly every way imaginable.
Faculty advisor for our first-place team in the national 2018 AACP Pharm4Me Innovation Challenge, and recently named a Fellow of the American Society of Consultant Pharmacists.
Recipient of a University at Buffalo 2018 Award for Teaching Innovation.
AAAS fellow and SUNY Distinguished Professor, and recipient of the 2018 American Association of Pharmaceutical Scientists Distinguished Service Award.
Recipient of a 2018 National Science Foundation CAREER Award and principal investigator on a $1.58 million grant from the National Institutes of Health.
Recently named an AAAS fellow, AAPS fellow, ISoP fellow, and received the 2017 ISoP Innovation Award for his contributions to computational and systems pharmacology.
Testing new strategies for improving the delivery of potent toxins to cancer cells with a $1.8 million grant from the National Cancer Institute.
Investigating how therapeutic antibodies are handled in the human lung with a $400,000 grant from the National Institute of Child Health and Human Development.
AAAS Fellow and SUNY Distinguished Professor, and recipient of the 2018 ASCPT Oscar B. Hunter Career Award in Therapeutics.
Leads an internationally-recognized research team in the fight against super bugs and antibiotic resistance.
Leading efforts in interprofessional education at the school and the university.
Recipient of a $3.5 million NIH grant to advance the development of personalized medicine for high-risk kidney transplant patients.
Recipient of AACP 2018 New Investigator Award to support his research in kidney dialysis treatment.